Expertise in
7
conditions

Emeline Tabouret

Marseille, FR 
Expertise in
7
conditions
Marseille, FR 

Overview

Emeline Tabouret practices practicing medicine in Marseille, France.

Ms. Tabouret is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Glioma, Gliomatosis Cerebri, Astrocytoma, Glioblastoma, and Vitrectomy.

She is actively involved in clinical research, co-authoring 120 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Marseille, France
Other Locations
Paris, France
2, Avenue Martin Luther King, Limoges, 87000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: Intensified Protocol, Stupp Protocol
Study Phase: Phase 3
Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Enrollment Status: Withdrawn
Publish Date: June 27, 2022
Intervention Type: Drug
Study Phase: Not Applicable
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
Enrollment Status: Terminated
Publish Date: May 21, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

120 Total Publications

Vorasidenib as monotherapy in grade 2 astrocytoma or oligodendroglioma with an IDH1 R132 or IDH2 R172 mutation
Vorasidenib as monotherapy in grade 2 astrocytoma or oligodendroglioma with an IDH1 R132 or IDH2 R172 mutation
Journal: Bulletin du cancer
Published: October 07, 2025

Frequently Asked Questions about Emeline Tabouret

Is Emeline Tabouret a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Emeline Tabouret is classified as an Elite expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emeline Tabouret participate in research or clinical trials?

Yes. Emeline Tabouret has published 120 articles and abstracts on conditions like Glioma. You can view a list of Emeline Tabouret's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Tabouret's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile